Dora Vallejo-Ardila: Highlights from First Day of MOGA 2025
Dora Vallejo-Ardila, Senior Medical Monitor/ Clinical Research Physician at Avance Clinical, shared a post on LinkedIn:
“First Day Highlights – MOGA 2025 (August 12, 2025)
1. Four‑in‑Twenty Practice‑Changing Updates (Breast, Upper GI, Prostate, Lung)
The afternoon symposium, Four‑in‑Twenty Practice‑Changing Updates, delivered focused advances across major cancer types, providing a perfect setting to discuss newly emerging radiopharmaceutical trials in Australia.
Co‑PSMA Head‑to‑Head Imaging Study
Led by Prof Louise Emmett at St Vincent’s Hospital, Sydney, this Phase II investigator‑initiated trial is comparing 64Cu‑SAR‑bisPSMA with the standard 68Ga‑PSMA‑11 for detecting disease recurrence post‑prostatectomy.
Prof Ben Tran’s pivotal work in Real‑World Data (RWD)—a critical pillar underpinning these translational and trial efforts. His efforts enable:
- Regulatory and Reimbursement Support: RWD evidence strengthens applications for national funding and approval.
- Refined Study Design: Using RWD to power adaptive and pragmatic trial methodologies.”
More posts featuring Dora Vallejo-Ardila on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023